Stock Report

Ganga Pharmaceuticals Ltd Q4 FY2023 profit at Rs. 0.77 lakhs



Posted On : 2023-05-18 20:45:03( TIMEZONE : IST )

Ganga Pharmaceuticals Ltd Q4 FY2023 profit at Rs. 0.77 lakhs

has reported Standalone financial results for the period ended March 31, 2023.

Financial Results (Q4 FY2023) - QoQ Comparison

The company has reported total income of Rs. 1.4126 crores during the period ended March 31, 2023 as compared to Rs. 1.4719 crores during the period ended December 31, 2022.

The company has posted net profit / (loss) of Rs. 0.0077 crores for the period ended March 31, 2023 as against net profit / (loss) of Rs. 0.0316 crores for the period ended December 31, 2022.

The company has reported EPS of Rs. 0.02 for the period ended March 31, 2023 as compared to Rs. 0.08 for the period ended December 31, 2022.

Financials Q4 FY2023 Q3 FY2023 % Change
Total Income ₹1.4126 crs ₹1.4719 crs Up Tick / Down Tick-4.03%
Net Profit ₹0.0077 crs ₹0.0316 crs Up Tick / Down Tick-75.63%
EPS ₹0.02 ₹0.08 Up Tick / Down Tick-75.00%

Financial Results (Q4 FY2023) - YoY Comparison

The company has reported total income of Rs.1.4126 crores during the period ended March 31, 2023 as compared to Rs.1.3970 crores during the period ended March 31, 2022.

The company has posted net profit / (loss) of Rs.0.0077 crores for the period ended March 31, 2023 as against net profit / (loss) of Rs.0.0331 crores for the period ended March 31, 2022.

The company has reported EPS of Rs.0.02 for the period ended March 31, 2023 as compared to Rs.0.08 for the period ended March 31, 2022.

Financials Q4 FY2023 Q4 FY2022 % Change
Total Income ₹1.4126 crs ₹1.3970 crs Up Tick / Down Tick1.12%
Net Profit ₹0.0077 crs ₹0.0331 crs Up Tick / Down Tick-76.74%
EPS ₹0.02 ₹0.08 Up Tick / Down Tick-75.00%

Financial Results (Year Ended FY2023) - YoY Comparison

The company has reported total income of Rs.2.8845 crores during the Financial Year ended March 31, 2023 as compared to Rs.2.7476 crores during the Financial Year ended March 31, 2022.

The company has posted net profit / (loss) of Rs.0.0393 crores for the Financial Year ended March 31, 2023 as against net profit / (loss) of Rs.0.0379 crores for the Financial Year ended March 31, 2022.

The company has reported EPS of Rs.0.10 for the Financial Year ended March 31, 2023 as compared to Rs.0.09 for the Financial Year ended March 31, 2022.

Financials Year Ended FY2023 Year Ended FY2022 % Change
Total Income ₹2.8845 crs ₹2.7476 crs Up Tick / Down Tick4.98%
Net Profit ₹0.0393 crs ₹0.0379 crs Up Tick / Down Tick3.69%
EPS ₹0.10 ₹0.09 Up Tick / Down Tick11.11%

Source : Equity Bulls

Keywords

GangaPharmaceuticals Q4FY23 FY2023 ResultUpdate